What is NuMedics?
NuMedics is a pioneer in diabetes disease management applications, offering software tools that aggregate data from various diabetes devices for evidence-based treatment. Their applications are designed for both clinicians and patients, facilitating data recording, sharing, and communication. The company provides integrated solutions that simplify health data tracking and enhance the management of diabetes. With over twenty years of experience, NuMedics aims to improve the standard of care through interactive and user-friendly disease management solutions.
How much funding has NuMedics raised?
NuMedics has raised a total of $45K across 1 funding round:
Debt
$45K
Debt (2021): $45K with participation from PPP
What's next for NuMedics?
Operating at a significant Series B/C stage, NuMedics is poised for substantial growth following its recent acquisition of expansion capital. The company's focus on aggregating data from diabetes devices for both clinicians and patients positions it as a key player in digital health and chronic disease management. Future strategic initiatives will likely involve further development of their integrated solutions, enhancing data analytics capabilities, and potentially expanding their market reach to new patient demographics or healthcare systems. This investment will fuel their mission to improve the standard of care in diabetes management.
See full NuMedics company page
